When are we prescribing gastric antisecretory agents?
Campo de Juan, M.; Vila Moneny, J.; Marques Gaspar, C.; Sanz López, J.
Atencion Primaria 18(8): 467
1996
ISSN/ISBN: 0212-6567 PMID: 9091055 Document Number: 468739
Document emailed within 1 workday
Related Documents
Esplugues, J.V.; García, A.G. 1991: New pharmacologic perspectives in the therapy with antisecretory agents: omeprazole Revista Clinica Espanola 188(6): 301-305Czeglédi, B.; Zsoldos, T.; Mózsik, G. 1984: Effect of PGF2 alpha administered in cytoprotective and antisecretory doses on the ethanol- and HCl-induced gastric mucosal damage and gastric mucosal superoxide dismutase activity in rats Acta Physiologica Hungarica 64(3-4): 331-337
Dajani, E.Z.; Bianchi, R.G.; Casler, J.J.; Weet, J.F. 1979: Gastric antiulcer and antisecretory effects of carbenoxolone, aldosterone and desoxycorticosterone in rats Archives Internationales de Pharmacodynamie et de Therapie 242(1): 128-138
Mugridge, K.G.; Perretti, M.; Ghiara, P.; Galeotti, C.L.; Melli, M.; Parente, L. 1995: Gastric antisecretory and anti-ulcer actions of IL-1 in rat involve different IL-1 receptor types American Journal of Physiology 269(5 Pt 1): G763-G769
Pellegrini, R.; Abbondati, G. 1976: Trithiozine (ISF 2001): gastric antisecretory effects and treatment of peptic ulcer Il Farmaco; Edizione Pratica 31(10): 483-494
Barzaghi, F.; Cesana, R.; Delevallée, F.; Fournex, R.; Nencioni, A.; Vincent, J.C.; Deraedt, R. 1985: Gastric cytoprotective, antisecretory and antiulcer activities of (E)-4-oxo-4-(3,4,5-trimethoxyphenyl)-2-butenoic acid (RU 38086) Arzneimittel-Forschung 35(9): 1412-1416
Galmiche, J.P.; Mignon, M.; Ducrotte, P.; Mayeur, S.; Arsene, D.; Vallot, T. 1981: Continuous recording of gastric pH to assess the efficacy of antisecretory drugs in Zollinger-Ellison syndrome La Nouvelle Presse Medicale 10(6): 432-433
Valcavi, U.; Caponi, R.; Brambilla, A.; Palmira, M.; Minoja, F.; Bernini, F.; Musanti, R.; Fumagalli, R. 1982: Gastric antisecretory, antiulcer and cytoprotective properties of 9-hydroxy-19,20-bis-nor-prostanoic acid in experimental animals Arzneimittel-Forschung 32(6): 657-663
Lippmann, W. 1971: Aspects of the gastric acid antisecretory activity of 3,3-dimethyl-1-(3-methylaminopropyl)-1-phenylphthalan: a blocker of norepinephrine uptake Archives Internationales de Pharmacodynamie et de Therapie 193(2): 340-356
Sütö, G.; Garamszegi, M.; Jávor, T.; Nagy, L.; Németh, A.; Vincze, A. 1990: Biochemical background of cimetidine-induced gastric mucosal prevention in rats treated with HCL (actions of cytoprotective and antisecretory doses) Acta Physiologica Hungarica 75 Suppl: 259-260
Nielsen, S.T.; Dove, P.A.; Strike, D.P.; Schiehser, G.A. 1987: Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity Drugs under Experimental and Clinical Research 13(5): 297-304
Murmann, W.; Carminati, G.M.; Cattaneo, R. 1974: Pharmacology of zolimidine (2-(p-methylsulfonylphenyl)-imidazo (1,2-a) pyridine) a new non-anticholinergic gastroprotective agent. III). Gastric antisecretory activity, antagonism against acid hypersecretion induced by pentagastrin and histamine, and other effects Panminerva Medica 16(10): 335-346
Torchiana, M.L.; Pendleton, R.G.; Cook, P.G.; Hanson, C.A.; Clineschmidt, B.V. 1983: Apparent irreversible H2-receptor blocking and prolonged gastric antisecretory activities of 3-N-(3-[3-(1-piperidinomethyl)phenoxy]propyl) amino-4-amino-1,2,5-thiadiazole-1-oxide (L-643, 441) Journal of Pharmacology and Experimental Therapeutics 224(3): 514-519
Roszkowski, A.P.; Garay, G.L.; Baker, S.; Schuler, M.; Carter, H. 1986: Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester Journal of Pharmacology and Experimental Therapeutics 239(2): 382-389
Schüler, P. 1996: Factors influencing the prescribing of nootropic agents Deutsche Medizinische Wochenschrift 121(12): 391
Goldblum, O.M. 2001: Electronic prescribing: criteria for evaluating handheld prescribing systems and an evaluation of a new, handheld, wireless wide area network (WWAN) prescribing system Dermatology Online Journal 7(1): 1
Ignatova, M.S.; Fokeeva, V.V.; Korovina, N.A.; Levitskaia, S.V. 1973: Differential approach to prescribing of immunodepressive agents to children with nephritis Sovetskaia Meditsina 36(10): 130-134
Toiber, F.; Murthy, V.S. 1991: Prescribing and usage patterns of two antihypertensive agents: a comparison of terazosin and enalapril Hospital Formulary 26(10): 811
Po, H.L.; Lin, Y-Ju.; Hseuh, I-Hung. 2009: The prescribing patterns of antithrombotic agents for prevention of recurrent ischemic stroke Acta Neurologica Taiwanica 18(2): 98-103
Laine, L. 1993: Helicobacter pylori, gastric ulcer, and agents noxious to the gastric mucosa Gastroenterology Clinics of North America 22(1): 117-125